Valuation: Scinai Immunotherapeutics Ltd.

Market Cap 1M 871K 812K 746K 1.41M 95.45M 1.43M 9.58M 3.74M 47.71M 3.77M 3.69M 158M P/E 2024 *
-
P/E 2025 -0.2x
Enterprise Value 1.61M 1.4M 1.3M 1.2M 2.26M 153M 2.29M 15.36M 6.01M 76.53M 6.04M 5.91M 254M EV / Sales 2024
4,521,684x
EV / Sales 2025 2,346,088x
Free-Float
0.36%
Yield 2024 *
-
Yield 2025 -
1 day-8.35%
1 week-5.23%
Current month-8.35%
1 month-7.47%
3 months-61.20%
6 months-72.57%
Current year-64.86%
1 week 0.23
Extreme 0.2302
0.38
1 month 0.21
Extreme 0.214701
0.38
Current year 0.21
Extreme 0.214701
1.12
1 year 0.21
Extreme 0.214701
1.97
3 years 0.21
Extreme 0.214701
13.9
5 years 0.21
Extreme 0.214701
349
10 years 0.21
Extreme 0.214701
6,199.99
Manager TitleAgeSince
Chief Executive Officer 51 02/03/2021
Director of Finance/CFO 55 01/01/2007
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 77 30/09/2019
Director/Board Member 64 24/03/2020
Director/Board Member 71 24/03/2020
Date Insider Type Main position Quantity % Market Cap.
1/1/23 Other

Director

1,200,000 0.1606%
1/1/23 Other

Director

4,000,000 0.5354%
1/1/23 Other

Chief Financial Officer

880,000 0.1178%
Change 5-day change 1-year change 3-year change Capi.($)
-8.35%-5.23%-83.43%-98.19% 1.08M
-0.68%-0.68%-1.63%+12.86% 48.22B
+6.03%+5.22%+420.33%+519.87% 38.79B
-2.21%-6.07%+24.87%+5.20% 38.41B
+2.94%-2.25%+6.15%+59.69% 34.88B
+1.98%+4.74%+12.19%+41.37% 29.19B
+0.47%-3.87% - - 16.05B
+0.31%+0.72%+32.99%+122.25% 16B
+1.59%+0.44%+3.43%+16.80% 13.53B
-0.98%-12.98%-4.82%-38.09% 12.22B
Average +0.11%+1.07%+45.56%+71.31% 24.73B
Weighted average by Cap. +1.21%+1.55%+78.99%+112.40%

Financials

2024 2025
Net sales 0.66 0.57 0.53 0.49 0.93 62.59 0.94 6.28 2.46 31.29 2.47 2.42 103.67 1.31 1.14 1.06 0.98 1.84 124.71 1.86 12.51 4.89 62.34 4.92 4.82 206.55
Net income 4.8M 4.16M 3.88M 3.57M 6.75M 456M 6.82M 45.78M 17.89M 228M 18.01M 17.62M 756M -8.31M -7.21M -6.73M -6.18M -11.68M -790M -11.81M -79.29M -31M -395M -31.2M -30.51M -1.31B
Net Debt 122K 106K 98.77K 90.73K 172K 11.6M 173K 1.16M 455K 5.8M 458K 448K 19.22M 606K 526K 491K 451K 852K 57.64M 862K 5.78M 2.26M 28.82M 2.28M 2.23M 95.48M
Logo Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Employees
45
Date Price Change Volume
04/08/26 US$0.2502 -8.35% 500,663
03/08/26 US$0.2730 0.00% 4,884,862
31/07/26 US$0.2730 -1.09% 123,861
30/07/26 US$0.2760 +3.49% 96,221
29/07/26 US$0.2667 +1.02% 67,383

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SCNI Stock